Impact of autologous HSCT on the quality of life and fatigue in patients with relapsing multiple sclerosis
Crossref DOI link: https://doi.org/10.1038/s41598-022-19748-7
Published Online: 2022-09-13
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Giedraitiene, N.
Gasciauskaite, G.
Kaubrys, G.
Text and Data Mining valid from 2022-09-13
Version of Record valid from 2022-09-13
Article History
Received: 7 June 2022
Accepted: 2 September 2022
First Online: 13 September 2022
Competing interests
: The authors declare no competing interests.